
Matt Seefeld is Executive Vice President at MedEvolve and Will Mowe is Executive Director of Rebound Orthopedics and Neurosurgery. Today, Rebound is achieving better bottom-line performance with fewer FTEs. Zero touch claims that require no human intervention now account for 62% of total, and a closed balance net collection rate above benchmark at 98%.
